Ultrasound-Guided Hydrodilatation With Triamcinolone Acetonide for Adhesive Capsulitis

General Hospital of Ningxia Medical University

Status: Enrolling

Conditions: Postoperation Pain

Treatments: Procedure: Ultrasound-Guided Hydrodilatation by the Rotator cuff interval recess; Procedure: Ultrasound-Guided Hydrodilatation by the Rotator cuff interval and posterior glenohumeral recess

Study type: Interventional

Funder types: Other

Identifiers

NCT06553716

Peng Ma-2024-0201

Details and patient eligibility

About

The purpose of this study was to compare the efficacy of ultrasus-guided hydrodilation of Rotator Cuff Interval combined with Posterior Glenohumeral recess approach and hydrodilation of the Rotator cuff Interval alone in Adhesive Capsulitis.

Full description

For patients with perihumeral arthritis, shoulder capsule hydrodilation is usually performed using ultrasound-guided water dilation through the posterior glenohumeral recess. Recently, a new transrotator cuff space approach has been described, and this study was designed to compare the efficacy of triamcinolone olonide transrotator cuff space combined with posterior glenohumeral recess and rotator cuff space dilation in the treatment of adhesive joint capsitis.

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Age ≥18 years old, clinical diagnosis of periarthritis of shoulder;
2. symptom duration > 1 month, shoulder ROM limitation in at least two directions, defined as abduction < 80°, flexion < 130°, and rotation < 30°;
3. Before enrollment, the patients received plain radiographs, ultrasound images, and magnetic resonance imaging to rule out the cause of secondary shoulder capsitis.

Exclusion criteria

1. Secondary frozen shoulder, such as rotator cuff tear, calcifying tendinitis, osteoarthritis, infection, tuberculosis infection, rheumatic disease, shoulder impingement syndrome;
2. Previous history of shoulder joint surgery;
3. Involved cervical nervous system symptoms or abnormal nervous system;
4. corticosteroid injection in the affected shoulder within 3 months;
5. Mental illness;
6. Patients with contraindications to cortisol-hormone use.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

70 participants in 2 patient groups

Rotator cuff space approach (GroupA)

Active Comparator group

Description:

In the Rotator cuff interval recess group,we injected 20 mL lidocaine with 2 mg/mL triamcinolone acetonide (Shincort) into into the Rotator cuff interval/anterior capsule.

Treatment:

Procedure: Ultrasound-Guided Hydrodilatation by the Rotator cuff interval recess

Rotator cuff space approach combined with posterior glenohumeral recess approach (GroupB)

Experimental group

Description:

In the Rotator cuff interval and posterior glenohumeral recess group,we injected 10 mL lidocaine with 2 mg/mL triamcinolone acetonide (Shincort) into the Rotator cuff interval/anterior capsule and 10 mL mL lidocaine with 2 mg/mL triamcinolone acetonide (Shincort) into the posterior glenohumeral.

Treatment:

Procedure: Ultrasound-Guided Hydrodilatation by the Rotator cuff interval and posterior glenohumeral recess